The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS ...

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2025 Earnings Call Transcript February 17, 2026 NeoGenomics, Inc. misses on earnings expectations. Reported EPS is $-0.38403 EPS, expectations were $0.04. Operator: ...

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) reported Q4 CY2025 results exceeding the market’s revenue ...

Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...

Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...

Q4 2025 Earnings Call February 17, 2026 8:30 AM ESTCompany ParticipantsKendra Sweeney - Vice President of Investor Relations ...

Q4 2025 earnings call recap: record revenue, RaDaR ST launch, 2026 guidance, margin outlook, and key risks—read now.

Unstructured announced today it has been awarded a $2 million Tactical Funding Increase (TACFI) contract by AFWERX in ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated Europe Genomic Cancer Panel and Profiling Market size by value at USD 2.62 billion in 2023. During ...

What is the Market Size of Precision Medicine Research and Development Platform? The global market for Precision Medicine ...

Creative Biolabs is accelerating gene therapy research globally with specialized expertise. SHIRLEY, NY, UNITED STATES, ...

Social Agent, the first app to deliver certified content creators on-demand, today announced its expansion into New York City ...